Advanced Practice Provider Core Curriculum: Benign Prostatic Hyperplasia (2022)

Member only benefit!Results of a recent survey sent to US based practicing urologists show that there has been an increase in the number of advanced practice providers (APPs) actively providing front-line urologic care. Based on these findings, it was determined that the AUA develop a modular curriculum to be used in advancing the standard of urologic education for APPs. This educational curriculum, developed in partnership with the Cleveland Clinic, is comprised of online videos targeted towards the most common reasons patients seek non-operative urologic care. This module provides an overview of BPH.

Target Audience

  • Physician Assistants
  • Advanced Practice Nurses

Learning Objectives

After completing this activity, the participant will be able to:

  1. Describe the pathophysiology of lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH).
  2. Explain and implement the recommended diagnostic evaluation of patients presenting with BPH.
  3. 描述作用机制,适应症和支持BPH医学治疗的证据。
  4. Identify indications for surgical treatment of BPH.
  5. Identify anatomic and patient-related factors that would favor the use of specific BPH-related surgical treatments.
Course summary
Available credit:
  • 2.75AMA PRA Category 1 Credit™
  • 2.75Non-Physician Participation
Course opens:
07/01/2022
Course expires:
07/01/2025
Rating:
0

FACULTY

Nima Almassi, MD:Nothing to disclose

COURSE DIRECTOR

Hadley Wood, MD:Boston Scientific: Scientific Study or Trial

REVIEWERS

Adele Caruso, MD:Nothing to disclose

PLANNER DISCLOSURES

PDF iconEducation Council Disclosures

PDF iconAdvanced Practice Providers Education Committee Disclosures

所有相关的财务关系都已缓和。

AUA Office of Education Staff has nothing to disclose.

METHOD OF PARTICIPATION:

Learners will participate in this online educational activity by viewing the webcast, completing the post-test and evaluation. To claim CME credit for this enduring material, learners must complete the post-test, passing with 80% accuracy, and submit the program evaluation.

Estimated time to complete this activity: 2.75 hours

Original Release Date: March, 2017
Renew Date: February, 2020
Renew Date: July, 2022
Expiration Date: July, 2025

ACCREDIDATION:

The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION:

The American Urological Association designates this enduring material for a maximum of 2.75AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OTHER LEARNERS:

The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified forAMA PRA Category 1 Credit™.

EVIDENCE BASED CONTENT:

It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA DISCLOSURE POLICY:

所有能够控制教育活动内容的人员(即活动策划人员、主持人、作者)都必须向提供商披露在过去24个月内与任何商业利益相关的所有财务关系。AUA必须确定个人的关系是否可能影响教育内容,并在教育活动开始之前减轻任何利益冲突。本披露的目的不是为了阻止有相关经济关系的个人参与,而是为了向学习者提供他们可以做出自己判断的信息。

MITIGATION OF IDENTIFIED CONFLICT OF INTEREST:

All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group Chair and/or Vice Chair for identification of conflicts of interest. The AUA COI Review Work Group, working with Office of Education staff, will document the mechanism(s) for management and mitigation of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to mitigate conflict of interest:

  • Peer review for valid, evidence-based content by the AUA COI Review Work Group.
  • Attestation that clinical recommendations are evidence-based and free of commercial bias.
  • Introduction of a debate format (point-counterpoint)
  • Inclusion of moderated panel discussion with unbiased moderator
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Divestiture of the relationship by faculty
  • Recusal from controlling relevant aspects of planning
  • Selection of alternative faculty for specific topic

OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES:

The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.


AUA PARTICIPANT INFORMATION & POLICIES

DISCLAIMER:

The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.

同意使用摄影图像:

Attendance at or participation in AUA meetings and other activities constitutes an agreement by the registrant to AUA's use and distribution (both now and in the future) of the attendee's image or voice in photographs and electronic reproductions of such meetings and activities.

AUDIO, VIDEO AND PHOTOGRAPHIC EQUIPMENT:

The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meeting rooms.

REPRODUCTION PERMISSION:

Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.

SPECIAL ASSISTANCE/ DIETARY NEEDS:

The AUA complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the registration desk.

Available Credit

  • 2.75AMA PRA Category 1 Credit™
  • 2.75Non-Physician Participation
Pleaseloginorregisterto take this course.